Transperineal prostate biopsy navigated with US/MRI fusion

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F21%3AE0108980" target="_blank" >RIV/00843989:_____/21:E0108980 - isvavai.cz</a>

Result on the web

<a href="https://www.czechurol.cz/pdfs/cur/2021/01/04.pdf" target="_blank" >https://www.czechurol.cz/pdfs/cur/2021/01/04.pdf</a>

DOI - Digital Object Identifier

—

Result language

čeština

Original language name

Transperineálně prováděné fúzní US/MRI navigované biopsie prostaty

Original language description

Major statement: US/MRI fusion transperineal prostate biopsy has comparable yield and lower risk of infectious complications than transrectal biopsy. Purpose: Nowadays, prostate biopsies performed transperineally are gaining prominence. In our cohort, we retrospectively evaluated the yield of transperineally performed biopsies and at the same time their safety, especially with regard to infectious complications. Patients and methods: From January 2019 to March 2020, we performed 208 fusion US/MRI guided prostate biopsies - transperineally. Magnetic resonance imaging was evaluated by the PI-RADS vs 2 and vs 2.1 scoring systems, respectively. In biopsy naive patients we performed systematic biopsy from the peripheral zone and took at least three samples from the lesion described by the radiologist. In patients with repeated biopsy, we made a targeted biopsy with at least three samples from the lesion or lesions PI-RADS ? 3, but we did not make a systematic biopsy. Results: The overall yield of the method in our group, regardless of the PI-RADS score, was 52.9 % of proven cancers in biopsy naive patients, of which 35.3 % were clinically insignificant and 17.6 % were clinically significant. In rebiopsy, 53.6 % of cancers were detected, of which 38.6 % were clinically insignificant and 15 % were clinically significant When comparing the yield according to the PI-RADS score, in the PI-RADS 3 group a total of 68.5 % were negative, 31.5 % positive (27.8 % insignificant and 3.7 % significant), in the PI-RADS 4 group it was 44.3 % negative and 55.7 % positive (41.8 % and 13.9 %, respectively), in the PI-RADS 5 group 22.9 % negative, 77.1 % positive (43.8 % and 33.3 %, respectively). There was a statistically significant difference in the yield of biopsies (Chi-square test of independence for contingency tables, P < 0.001). We also assessed the complications of the procedure and we found that 182 patients underwent the procedure without any complications. As our main outc...

Czech name

Transperineálně prováděné fúzní US/MRI navigované biopsie prostaty

Czech description

Major statement: US/MRI fusion transperineal prostate biopsy has comparable yield and lower risk of infectious complications than transrectal biopsy. Purpose: Nowadays, prostate biopsies performed transperineally are gaining prominence. In our cohort, we retrospectively evaluated the yield of transperineally performed biopsies and at the same time their safety, especially with regard to infectious complications. Patients and methods: From January 2019 to March 2020, we performed 208 fusion US/MRI guided prostate biopsies - transperineally. Magnetic resonance imaging was evaluated by the PI-RADS vs 2 and vs 2.1 scoring systems, respectively. In biopsy naive patients we performed systematic biopsy from the peripheral zone and took at least three samples from the lesion described by the radiologist. In patients with repeated biopsy, we made a targeted biopsy with at least three samples from the lesion or lesions PI-RADS ? 3, but we did not make a systematic biopsy. Results: The overall yield of the method in our group, regardless of the PI-RADS score, was 52.9 % of proven cancers in biopsy naive patients, of which 35.3 % were clinically insignificant and 17.6 % were clinically significant. In rebiopsy, 53.6 % of cancers were detected, of which 38.6 % were clinically insignificant and 15 % were clinically significant When comparing the yield according to the PI-RADS score, in the PI-RADS 3 group a total of 68.5 % were negative, 31.5 % positive (27.8 % insignificant and 3.7 % significant), in the PI-RADS 4 group it was 44.3 % negative and 55.7 % positive (41.8 % and 13.9 %, respectively), in the PI-RADS 5 group 22.9 % negative, 77.1 % positive (43.8 % and 33.3 %, respectively). There was a statistically significant difference in the yield of biopsies (Chi-square test of independence for contingency tables, P < 0.001). We also assessed the complications of the procedure and we found that 182 patients underwent the procedure without any complications. As our main outc...

Type

J_ost - Miscellaneous article in a specialist periodical

CEP classification

—

OECD FORD branch

30217 - Urology and nephrology

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2021

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Česká urologie

ISSN

1211-8729

e-ISSN

2336-5692

Volume of the periodical

25

Issue of the periodical within the volume

1

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

8

Pages from-to

27-34

UT code for WoS article

—

EID of the result in the Scopus database

—